BindingDB logo
myBDB logout

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28435528 24 Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.EBI Kezar Life Sciences
25006746 85 Structure-based design of฿1i or฿5i specific inhibitors of human immunoproteasomes.EBI Leiden Institute of Chemistry and Netherlands Proteomics Centre
30380863 196 Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide).EBI Kezar Life Sciences
31521028 67 Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases.EBI Hangzhou Xixi Hospital
30657666 263 Structure-Based Design of Inhibitors Selective for Human Proteasome ?2c or ?2i Subunits.EBI Leiden Institute of Chemistry and Netherlands Proteomics Centre
30455150 10 Tetradehydrohalicyclamine B, a new proteasome inhibitor from the marine sponge Acanthostrongylophora ingens.EBI Kumamoto University
29339252 124 Structure-based design of human immuno- and constitutive proteasomes inhibitors.EBI Universit£
29782167 48 Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides.EBI University of Glasgow